Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

INSANE: 6 - The Real Truth

Nearly half of working mothers have been diagnosed with anxiety or depression. Here’s what can help

The country’s working moms are facing a mental health crisis.

Fortune · Mar 17, 2023

CEO Karen Lynch says CVS's acquisition spree will make health care simpler and more affordable

The pharmacy chain is in the process of buying Signify and Oak Street Health.

Fortune · Mar 9, 2023

Why CVS Health CEO Karen Lynch wore a 'taking up space' T-shirt on her first day

As CVS starts offering primary care services, the CEO talks full-service health care.

Fortune · Mar 8, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

2 Stocks on Track for Massive Gains in 2023

While Federal Reserve Chair Jerome Powell is trying to steer the economy toward a ‘soft landing,’ a strong job market will likely keep the Fed wary. Meanwhile, as investors mull over the Fed’s next steps, the market could remain volatile for some time. Hence, investing in fundamentally sound stocks, CVS…

StockNews.com · Feb 20, 2023

CVS buying Chicago’s Oak Street Health in deal valued at $10.6 billion

CHICAGO — CVS Health plans to buy Chicago-based Oak Street Health in a $10.6 billion deal that aims to expand CVS’s reach into primary care.

Chicago Tribune · Feb 8, 2023

3 Winning Stocks to Buy No Matter What the Market Does

Continuing improvements in economic indicators reflect that the U.S. economy is resilient amid the weak earnings forecasts. However, since the market is expected to remain under pressure for some time, it could be wise to add winning stocks, Oracle Corp. (ORCL), CVS Health (CVS), and Halliburton (HAL), to your portfolio.…

StockNews.com · Feb 8, 2023

CVS buys Chicago-based Oak Street Health for $10.6B

Oak Street Health runs primary care centers mostly for lower-to-middle income people with Medicare Advantage plans.

Chicago Sun-Times · Feb 8, 2023

Read news from The Economist, FT, and more,
with one subscription

CVS acquires Oak Street primary care for $10.6 billion

CVS Health is plunging deeper into providing primary care with an approximately $10.6 billion deal to acquire Oak Street Health

The Independent UK · Feb 8, 2023

Owning These 3 Stocks Could Make You Rich in 10 Years

Consistently falling prices and stronger-than-expected fourth-quarter GDP are renewing hopes about the economy’s overall health. Therefore, it could be wise to add quality stocks with solid fundamentals, Walmart (WMT), Bristol-Myers Squibb (BMY), and CVS Health (CVS), to your portfolio to garner substantial returns in 10 years. Read more….

StockNews.com · Feb 1, 2023

5 Unstoppable Stocks You Shouldn't Wait Any Longer to Buy

The Fed’s intention to keep raising interest rates despite the cooling down of inflation could eventually lead to the economy witnessing a recession. Moreover, the World Bank lowered its 2023 global growth forecast by almost half, citing deteriorating economic conditions. Hence, it could be wise to invest in fundamentally sound…

StockNews.com · Jan 27, 2023

3 Hyper-Growth Stocks to Buy for Big Gains

With recent economic data showing promise, the chances of a soft landing for the economy are increasing. Hence, it could be wise to invest in fundamentally sound stocks CVS Health (CVS), Ooma (OOMA), and Neurocrine Biosciences (NBIX), which possess solid growth attributes. Read on….

StockNews.com · Dec 28, 2022

3 Health Care Stocks That Could Help You Make a Fortune

Although inflation is showing signs of cooling down and the Fed indicated a slower pace of interest rate hikes, recession fears loom. Thanks to the resilient demand for its products and services, the healthcare industry is expected to survive a challenging macroeconomic environment better than many industries. Thus, it could…

StockNews.com · Dec 16, 2022

4 Stocks With More Room to Run in 2023

Inflation eased again in November, which could allow the Fed to slow interest-rate hikes into the following year. Overall, the odds of the economy avoiding an anticipated recession are increasing. Given this backdrop, quality stocks CVS Health (CVS), ADT (ADT), ODP Corporation (ODP), and Universal Logistics (ULH) will likely see…

StockNews.com · Dec 14, 2022

The 4 Fastest-Growing Stocks to Purchase Right Now

Markets have been highly volatile this year due to macroeconomic and geopolitical headwinds. However, signs of slowing inflation and dovish comments from the Fed Chair have renewed investor appetite for riskier assets. Hence, it could be wise to invest in the fastest-growing stocks, CVS Health (CVS), McKesson (MCK), Celestica (CLS),…

StockNews.com · Dec 9, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune · Dec 8, 2022

How the best leaders are preparing to navigate a recession—and come out ahead

Current and former corporate leaders share their battle-tested playbooks with Fortune.

StockNews.com · Dec 5, 2022

3 Hot Stocks With More Room to Run in 2023

As inflation shows signs of easing and the Fed is expected to slow the pace of rate hikes, the market’s prospects look bright. Therefore, fundamentally strong stocks CVS Health (CVS), Archer-Daniels-Midland (ADM), and Box (BOX) could keep soaring. Wall Street analysts expect upsides in these stocks over the next 12…

StockNews.com · Nov 24, 2022

The 4 Best Growth Stocks to Buy Into 2023

With the Fed indicating that the pace of rate hikes might slow down, growth stocks could see a rebound. Therefore, it could be wise to buy CVS Health (CVS), Archer-Daniels-Midland (ADM), The Mosaic Company (MOS), and MaxLinear (MXL), which possess solid growth attributes. Keep reading….

WEKU · Nov 15, 2022

Walmart offers to pay $3.1 billion to settle opioid lawsuits

The retail giant becomes the latest major player in the drug industry to announce a plan to settle lawsuits filed by state and local governments over the toll of opioids sold at its pharmacies.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com · Nov 9, 2022

4 Health Care Stocks That Could Keep Your Portfolio From Needing a Check-Up

The healthcare industry tends to withstand macroeconomic pressure better than other industries due to the almost inelastic demand for medical products and services. With a recession expected next year, investors could look to capitalize on the defensive characteristics and long-term prospects of the industry by investing in quality medical stocks…

France 24 · Nov 2, 2022

US pharmacies announce opioid settlements totaling $10 billion

The two largest US pharmacy chains, CVS Health and Walgreen Co., announced agreements in principle on Wednesday to pay about $5 billion each to settle lawsuits nationwide over the toll of opioids, and a lawyer said Walmart, a third pharmacy behemoth, is in discussions for a deal.

Benzinga · Nov 2, 2022

CVS Health Unusual Options Activity

Someone with a lot of money to spend has taken a bearish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

WEKU · Nov 2, 2022

CVS and Walgreens announce opioid settlements totaling $10 billion

It could amount to the last round of huge settlements after years of litigation over the industry's role in an overdose crisis linked to more than 500,000 deaths in the U.S. over the past two decades.

Benzinga · Nov 2, 2022

Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02

Reuters

The Independent UK · Nov 2, 2022

CVS Health agrees to $5B settlement of opioid lawsuits

CVS Health says it has agreed to pay about $5 billion to state, local and Native American tribal governments to settle lawsuits over the toll of opioids

Benzinga · Oct 20, 2022

Check Out What Whales Are Doing With CVS

Someone with a lot of money to spend has taken a bullish stance on CVS Health (NYSE:CVS). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

1 … 5 6 7 8

Coverage From

People

Dipanjan BanchurSince

722 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.